PHOENIX OITB

Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products
An @EU_H2020 funded project under GA no. 953110 🇪🇺

[PHOENIX OITB @phoenixoitb]

Stay with us!

The PHOENIX consortium met in Madrid at @CSIC to discuss the future of our project & the PHOENIX SEP.

We're leaving this platform. Make sure to follow our news via PHOENIX OITB & PHOENIX SEP on LinkedIn.

Or subscribe to our newsletter! https://t.co/iEL4ZbOfSa

[PHOENIX OITB @phoenixoitb]

Topas Therapeutics is focused on developing nanoparticle-based drug products to address areas of major unmet need, including autoimmune diseases.

Watch our interview to learn how they used the services of PHOENIX-OITB guided by PHOENIX SEP:

https://t.co/LHNF9G1viG

[PHOENIX OITB @phoenixoitb]

PHOENIX was represented last week in the stunning Kuppelsaal of TU Wien at the acib Mini-Symposium "Enhanced Sustainability in Pharma".

PHOENIX services were presented in an overview of initiatives with ties to Austria, and we welcomed interested attendees to our booth.

[PHOENIX OITB @phoenixoitb]

This year we have 3 partners on Stanford's "Top 2% Scientists" list. Congrats to
- Ivana Vinković Vrček (IMI),
- Johannes Khinast (@RCPE )
for making the 2024 list, and

- Jesus M de la Fuente (@CSIC)
for making the "career-long" list of top-cited resesarchers!

🔬 🎉

[PHOENIX OITB @phoenixoitb]

A valuable day spent with the #NABIHEAL team in Barcelona: @Asphalion & IMI organized a workshop on regulatory frameworks for #medicaldevices containing #nanomaterials and for #nanomedicines. Thanks to all involved! 👏

[PHOENIX OITB @phoenixoitb]

Thrilled to have 2 partners together at #PODD2024 - Partnership Opportunities in Drug Delivery - in #Boston!

Visit us at:
@nanomoltech (Booth 48) and
@MyBiotechGmbH (Booth 12)
to learn about the PHOENIX-OITB services accessed via our single entry point, PHOENIX SEP.

[PHOENIX OITB @phoenixoitb]

Are you at #CPHIMilan this week?

Visit PHOENIX partner @nanomoltech at stand 18C7, zone Pharma Machinery and Equipment, to learn more about PHOENIX services for #nanopharmaceutical development!

Find out more about them via their video: https://t.co/3KqCivZhCk

[PHOENIX OITB @phoenixoitb]

Our upcoming webinar speakers represent our 5 service areas:
- Physico-chemical characterization
- In vitro characterization
- In vivo characterization
- Manufacturing
- Regulatory support

(Not pictured: speaker Johannes Khinast @RCPE )

Register now!
https://t.co/ZKAhwCYuYQ

[PHOENIX OITB @phoenixoitb]

The Agenda for our webinar is here!

Register now to hear from our speakers about the services of the PHOENIX-OITB, and how they can benefit companies and researchers.

#OITB #nanopharmaceuticals #nanomedicine #pharma #CMC #characterization #regulation #regulatorycompliance

[PHOENIX OITB @phoenixoitb]

*Important announcement: Satellite Event moved ONLINE!*

Due to requests to expand our introductory event of the PHOENIX-OITB services to a wider audience, we have decided to move the event entirely online!

➡️Register here: https://t.co/sGYbw2Ikn4

[PHOENIX OITB @phoenixoitb]

We're introducing PHOENIX to the pharma industry and SMEs interested accessing services in #nanopharmaceutical development from a Single-Entry-Point!

Join us in Graz 🇦🇹 on Friday, Sept 13th, 10am-1pm followed by a networking lunch.

Register here: https://t.co/W6utnFKZDy

[PHOENIX OITB @phoenixoitb]

Lange Nacht der Forschung in 🇦🇹:

In Linz, RECENDT explained non-destructive testing & measurement of food products or #nanoparticles.

In Graz, @RCPE used muesli & candy to show features of #nanopharmaceutical production while @bionanonet let kids discover #nano in nature.

[PHOENIX OITB @phoenixoitb]

Thank you #IndTech2024 for having our scientific coordinator @NazendeGT present PHOENIX at the #OITB satellit event today in Namur🇧🇪

Great to network and share knowledge & experience with other Open Innovation Test Beds.

PHOENIX Single Entry Point: https://t.co/L3TPW3WfV0

[PHOENIX OITB @phoenixoitb]

Curious if the PHOENIX Open Call is right for you?

Our interview with Scientific Coordinator @NazendeGT shows potential applicants the process for getting funded services in nanopharmaceutical development!

https://t.co/O2taiua3Ks

#h2020
#EUfunding #GMP

[PHOENIX OITB @phoenixoitb]

PHOENIX will be represented at #ETPN2024 by @susanne_resch of @bionanonet.

Take advantage of the early bird deadline and learn more about #nanomedicine and our single entry point for #nanopharmaceutical innovation: PHOENIX SEP!

[ETP Nanomedicine @etpnanomedicine]

🚀 Just in: #ETPN2024 Early Bird deadline extended to April 30! Seize the chance to join Europe's leading #nanomedicine event in #Milan. Connect, collaborate, and drive innovation. Grab your spot ➡️ https://t.co/pnRqDwXQrG 🔬💡 Meet the minds shaping the future of #healthtech.

[PHOENIX OITB @phoenixoitb]

Less than 1 month to go! Apply by May 3rd to receive funded access to a broad range of services in nanopharmaceutical development!
#H2020 #funding #OpenCall #Nanopharmaceuticals

[PHOENIX OITB @phoenixoitb]

*OPEN CALL ROUND 2 HAS LAUNCHED!*

Apply for the 2nd round of our Open Call for funded services in the #nanopharmaceutical development areas:

- Physico-Chemical Characterization
- In vitro Characterisation
- In vivo Characterisation
- Manufacturing

https://t.co/bXKlNPUFFM

[PHOENIX OITB @phoenixoitb]

PHOENIX OITB was well represented in the the latest @bionanonet QUARTERLY!

Take a look here: https://t.co/Tk1vzYgj8j
Don't forget to subscribe to get 4 issues a year to your inbox: https://t.co/PiFREfaqBN

[PHOENIX OITB @phoenixoitb]

At the 14th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (#PBPWorldMeeting) in Vienna from 18-21 March, @susanne_resch of @bionanonet presented a poster for PHOENIX-OITB.

The event attracted hundreds from industry and research in pharma.

[PHOENIX OITB @phoenixoitb]

Last month, @aetureli @MyBiotechGmbH traveled to Los Angeles to present PHOENIX at the Drug Delivery Summit.

Great opportunity to gain insights into the US market and bring attention to European innovation, PHOENIX & our Single Entry Point for nanopharmaceutical development.

[PHOENIX OITB @phoenixoitb]

Yesterday the work package leaders of the PHOENIX OITB project met at the facilities of @MyBiotechGmbH in Überherrn, Germany with our project advisor and monitor for our M36 Review Meeting.

We are grateful for the good questions, suggestions and constructive criticism.